EDGAR Filing Documents for 0001171843-17-005063

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-17-005063

Filing Date

2017-08-15

Accepted

2017-08-14 17:31:18

Documents

Period of Report

2017-08-14

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_081417.htm	6-K	13328
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	263453
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	315415
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	10164
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	10758
6	GRAPHIC	logo.jpg	GRAPHIC	8948
	Complete submission text file	0001171843-17-005063.txt		626566

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)